drugset

drugset / Trial / NCT03674476

An Investigational Study to Evaluate Experimental Medication BMS-986036 in Participants With Different Levels of Kidney Function

NCT03674476 ↗

Phase 1 Completed 40 enrolled Bristol-Myers Squibb

Non-randomizedParallel-groupOpen-labelTreatment

Summary

This is an investigational study to evaluate the experimental medication BMS-986036 in participants with different levels of kidney function.

Timeline

Start: 2018-09-11
Primary completion: 2019-06-24
Completion: 2019-06-24

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Pegbelfermin	Protein / enzyme biologic	—	—

Indications